Ozempic

Rich woman lounging on boat
Success

The wealthy 1% are turning to new status symbols that can’t be bought—and it’s hurting Dior, Versace, and Burberry

By
December 3, 2025
Donald Trump
Health

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

By
November 6, 2025
A fruitist snack cup with jumbo-sized blueberries is depicted on a table.
C-Suite

Ray Dalio is backing a $1 billion blueberry unicorn that sells berries nearly the size of golf balls

By
November 4, 2025
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
Health

Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro

By Matty Merritt and Morning Brew
October 31, 2025
Ozempic
Health

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

By
August 18, 2025
Ozempic
Commentary

Trump wants Medicare to pay for your Ozempic treatment. Taxpayers may foot the bill for billions in fraud

By Ari Yampolsky and Max Voldman
August 12, 2025
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
Newsletters

Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers

By
August 7, 2025
Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’
C-Suite

Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’

By
July 29, 2025
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
Finance

Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee

By
June 17, 2025
Ozempic CEO’s exit from Novo started with Teams call surprise
Finance

Ozempic CEO’s exit from Novo started with Teams call surprise

By Naomi Kresge and Bloomberg
May 16, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
Health

Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars

By
May 9, 2025
Novo Nordisk slides on pressure from Lilly’s pill study
Retail

Novo Nordisk slides on pressure from Lilly’s pill study

By Marthe Fourcade and Bloomberg
April 22, 2025
Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?
Magazine

Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?

By
March 31, 2025
Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher
Finance

Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher

By
March 7, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
Commentary

The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up

By
March 4, 2025

Most Popular